デンカ株式会社

Business Categories

Possibility of Chemistry

Electronics & Innovative Products The Division strives to build a prosperous society through innovative materials that are essential for 5G communications, xEV and renewable energy, including conductive additives for lithium-ion batteries, heat-dissipating materials and substrates, and functional ceramics, films and tapes.

Life Innovation The Division works to improve people's quality of life throughout the world in the fields of prevention, diagnosis and treatment, including influenza vaccines, test reagents such as rapid testing kits for COVID-19.

Elastomers & Infrastructure Solutions Utilizing the carbide-chain in place since the company's establishment, the Division has been supporting safe and secure lives with a wide range of organic and inorganic technologies, including functional elastomers, special admixtures needed for infrastructure toughening, along with corrugated pipes and fertilizers for agriculture.

Polymer Solutions From styrene-based performance plastics and acetyl chemicals to food packaging sheets and synthetic fibers for wigs, the Division works to support people's lives and build a sustainable society across a wide range of applications including vehicles, electrical machinery and appliances, electronic materials and food.

News Release

2026/3/26

IR Information

Notice Regarding Results of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)

2026/3/26

IR Information

Announcement of Extraordinary Gains (Gain on Sale of Investment Securities)

2026/3/11

IR Information

Summary of Q&A Session for Management Presentation on Feb 27 2025

2026/3/9

IR Information

Notice Concerning Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary)

2026/3/5

IR Information

Presentation Materials for Management Presentation on Feb 27 2026 with Script

2026/3/5

IR Information

(Amendment) Notice Regarding Amendment to “Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)” and Public Notice of Commencementof Tender Offer Dueto Filingof Amendment Statement

2026/2/27

IR Information

Notice of Formulation of Management Plan “Mission 2030” Phase 2 (FY2026–FY2028)

List

News List

This website uses cookies to ensure that you use this website comfortably.
If you continue to browse this website, you will agree to the use of our cookies.

Denka Group Protection of Personal Information Basic Policy